160 related articles for article (PubMed ID: 7759952)
1. CD30 and type 2 T helper (Th2) responses.
Romagnani S; Del Prete G; Maggi E; Chilosi M; Caligaris-Cappio F; Pizzolo G
J Leukoc Biol; 1995 May; 57(5):726-30. PubMed ID: 7759952
[TBL] [Abstract][Full Text] [Related]
2. CD30, Th2 cytokines and HIV infection: a complex and fascinating link.
Del Prete G; Maggi E; Pizzolo G; Romagnani S
Immunol Today; 1995 Feb; 16(2):76-80. PubMed ID: 7888070
[TBL] [Abstract][Full Text] [Related]
3. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition.
Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M; Pizzolo G
Eur J Immunol; 1996 Feb; 26(2):329-34. PubMed ID: 8617299
[TBL] [Abstract][Full Text] [Related]
4. CD30-mediated signaling promotes the development of human T helper type 2-like T cells.
Del Prete G; De Carli M; D'Elios MM; Daniel KC; Almerigogna F; Alderson M; Smith CA; Thomas E; Romagnani S
J Exp Med; 1995 Dec; 182(6):1655-61. PubMed ID: 7500010
[TBL] [Abstract][Full Text] [Related]
5. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection.
Manetti R; Annunziato F; Biagiotti R; Giudizi MG; Piccinni MP; Giannarini L; Sampognaro S; Parronchi P; Vinante F; Pizzolo G; Maggi E; Romagnani S
J Exp Med; 1994 Dec; 180(6):2407-11. PubMed ID: 7964515
[TBL] [Abstract][Full Text] [Related]
6. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines.
Del Prete G; De Carli M; Almerigogna F; Daniel CK; D'Elios MM; Zancuoghi G; Vinante F; Pizzolo G; Romagnani S
FASEB J; 1995 Jan; 9(1):81-6. PubMed ID: 7821763
[TBL] [Abstract][Full Text] [Related]
7. Allergen-induced CD30 expression on T cells of atopic asthmatics.
Leonard C; Tormey V; Faul J; Burke CM; Poulter LW
Clin Exp Allergy; 1997 Jul; 27(7):780-6. PubMed ID: 9249270
[TBL] [Abstract][Full Text] [Related]
8. Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration.
Krampera M; Vinante F; Tavecchia L; Morosato L; Chilosi M; Romagnani S; Zanolin ME; Pizzolo G
Clin Exp Immunol; 1999 Aug; 117(2):291-7. PubMed ID: 10444260
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis.
Dummer W; Bröcker EB; Bastian BC
Br J Dermatol; 1997 Aug; 137(2):185-7. PubMed ID: 9292064
[TBL] [Abstract][Full Text] [Related]
10. Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individuals.
Maggi E; Annunziato F; Manetti R; Biagiotti R; Giudizi MG; Ravina A; Almerigogna F; Boiani N; Alderson M; Romagnani S
Immunity; 1995 Aug; 3(2):251-5. PubMed ID: 7648397
[TBL] [Abstract][Full Text] [Related]
11. Role for CD30 antigen in human T helper 2-type responses.
Romagnani S
Ciba Found Symp; 1995; 195():55-62; discussion 62-7. PubMed ID: 8724830
[TBL] [Abstract][Full Text] [Related]
12. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells.
D'Elios MM; Romagnani P; Scaletti C; Annunziato F; Manghetti M; Mavilia C; Parronchi P; Pupilli C; Pizzolo G; Maggi E; Del Prete GF; Romagnani S
J Leukoc Biol; 1997 May; 61(5):539-44. PubMed ID: 9129201
[TBL] [Abstract][Full Text] [Related]
13. Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells.
Bengtsson A; Lundberg M; Avila-Cariño J; Jacobsson G; Holmgren A; Scheynius A
Clin Exp Immunol; 2001 Mar; 123(3):350-60. PubMed ID: 11298119
[TBL] [Abstract][Full Text] [Related]
14. CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role.
Gerli R; Pitzalis C; Bistoni O; Falini B; Costantini V; Russano A; Lunardi C
J Immunol; 2000 Apr; 164(8):4399-407. PubMed ID: 10754341
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD30 levels in plasma and cerebrospinal fluid in multiple sclerosis, HIV infection and other nervous system diseases.
Navikas V; Martin C; Matusevicius D; Söderström M; Fredrikson S; Link H
Acta Neurol Scand; 1997 Feb; 95(2):99-102. PubMed ID: 9059729
[TBL] [Abstract][Full Text] [Related]
16. CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis.
Yamamoto J; Adachi Y; Onoue Y; Kanegane H; Miyawaki T; Toyoda M; Seki T; Morohashi M
Allergy; 2000 Nov; 55(11):1011-8. PubMed ID: 11097309
[TBL] [Abstract][Full Text] [Related]
17. Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease?
Smith KJ; Barrett TL; Neafie R; Tomaszewski MM; Yeager J; Nelson A; Wagner KF; Skelton HG
Br J Dermatol; 1998 May; 138(5):774-9. PubMed ID: 9666821
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD30 serum level--an adequate marker for allograft rejection of solid organs?
Schlaf G; Altermann WW; Rothhoff A; Seliger B
Histol Histopathol; 2007 Nov; 22(11):1269-79. PubMed ID: 17647199
[TBL] [Abstract][Full Text] [Related]
19. CD30 expression does not discriminate between human Th1- and Th2-type T cells.
Hamann D; Hilkens CM; Grogan JL; Lens SM; Kapsenberg ML; Yazdanbakhsh M; van Lier RA
J Immunol; 1996 Feb; 156(4):1387-91. PubMed ID: 8568238
[TBL] [Abstract][Full Text] [Related]
20. Peripheral T lymphocyte cytokine profile (IFNgamma, IL-2, IL-4) and CD30 expression/release during measles infection.
Vinante F; Krampera M; Morosato L; Rigo A; Romagnani S; Pizzolo G
Haematologica; 1999 Aug; 84(8):683-9. PubMed ID: 10457402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
